Published in Surg Endosc on September 21, 2013
Transanal total mesorectal excision: full steam ahead. Tech Coloproctol (2015) 1.27
True NOTES TME resection with splenic flexure release, high ligation of IMA, and side-to-end hand-sewn coloanal anastomosis. Surg Endosc (2016) 0.92
Transanal total mesorectal excision: Towards standardization of technique. World J Gastroenterol (2015) 0.89
Transanal Endoscopic Microsurgery. Clin Colon Rectal Surg (2015) 0.84
Transanal Total Mesorectal Excision: A Novel Approach to Rectal Surgery. Clin Colon Rectal Surg (2017) 0.75
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients. World J Surg Oncol (2016) 0.75
Feasibility of transanal endoscopic total mesorectal excision for rectal cancer: results of a pilot study. Ann Surg Treat Res (2016) 0.75
Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75
Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med (2006) 12.50
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med (1997) 9.99
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol (2006) 7.05
Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture. Br J Surg (1984) 3.82
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg (2004) 3.50
The 'Holy Plane' of rectal surgery. J R Soc Med (1988) 3.22
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol (2003) 2.69
Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol (2005) 2.60
Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group. Ann Surg Oncol (1996) 2.27
Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum (2004) 2.01
The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2003) 1.93
Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg (2005) 1.83
Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg (2005) 1.65
A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum (1997) 1.58
Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg (2001) 1.43
A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc (2007) 1.37
Local excision of rectal cancer: what is the evidence? Dis Colon Rectum (2001) 1.36
Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial. J Clin Oncol (2004) 1.24
Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer (1995) 1.23
Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys (1998) 1.20
Prospective analysis of the distal margin of clearance in anterior resection for rectal carcinoma. Br J Surg (1996) 1.18
Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon Rectum (2010) 1.17
Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results. Ann Surg (1995) 1.15
Distal intramural spread in adenocarcinoma of the lower third of the rectum treated with total rectal resection and coloanal anastomosis. Dis Colon Rectum (1997) 1.03
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg (2007) 1.02
Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol (1998) 1.01
Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience. Surg Endosc (2008) 1.00
Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer. Dis Colon Rectum (1994) 0.89
Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc (2009) 0.87
The reality of radical sphincter preservation surgery for cancer of the distal 3 cm of rectum following high-dose radiation. Int J Radiat Oncol Biol Phys (1993) 0.86
Transanal endoscopic microsurgical excision of pT2 rectal cancer: results and possible indications. Dis Colon Rectum (2007) 0.86
High-dose preoperative radiation and the challenge of sphincter-preservation surgery for cancer of the distal 2 cm of the rectum. Int J Radiat Oncol Biol Phys (1998) 0.86
Surgical treatment of tumors of the distal rectum with sphincter preservation. Ann Surg (1992) 0.84
Radical Sphincter preservation surgery with coloanal anastomosis following high-dose external irradiation for the very low lying rectal cancer. Recent Results Cancer Res (1998) 0.84
Long-term follow-up of local rectal cancer surgery by transanal endoscopic microsurgery. World J Surg (2008) 0.84
DISCUSSION ON THE TREATMENT OF CARCINOMA OF THE RECTUM. Proc R Soc Med (1924) 0.75
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet (2005) 10.11
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol (2010) 5.65
Neoadjuvant chemoradiation in rectal cancer: time to start in a new direction. J Clin Oncol (2011) 2.05
Stereotactic navigation for TAMIS-TME: opening the gateway to frameless, image-guided abdominal and pelvic surgery. Surg Endosc (2014) 1.89
The Cassava Genome: Current Progress, Future Directions. Trop Plant Biol (2012) 1.75
Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3. Cancer Biol Ther (2002) 1.51
Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3. Cancer Biol Ther (2002) 1.47
Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer (2002) 1.34
Role of tumor necrosis factor-alpha and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma. Cancer Res (2007) 1.28
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys (2006) 1.24
Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys (2004) 1.18
Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for endothelial apoptosis. Cancer Biol Ther (2005) 1.11
Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03. Am J Clin Oncol (2007) 1.08
Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines. Clin Cancer Res (2003) 1.06
Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation. Int J Cancer (2008) 1.05
Accurate identification and analysis of human mRNA isoforms using deep long read sequencing. G3 (Bethesda) (2013) 1.03
Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group. Gynecol Oncol (2011) 1.00
Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2. J Biol Chem (2001) 0.98
Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials. J Urol (2003) 0.98
Management of rectal cancer: short- vs. long-course preoperative radiation. Int J Radiat Oncol Biol Phys (2008) 0.94
Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. Oncogene (2002) 0.94
Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm. Int J Radiat Oncol Biol Phys (2004) 0.92
Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm. Int J Radiat Oncol Biol Phys (2007) 0.91
Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells. Mol Cancer Ther (2011) 0.89
Low dose fractionated radiation potentiates the effects of taxotere in nude mice xenografts of squamous cell carcinoma of head and neck. Cell Cycle (2004) 0.87
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer. Clin Cancer Res (2004) 0.87
The impact of TNF-alpha induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation. Technol Cancer Res Treat (2002) 0.86
Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells. Anticancer Res (2002) 0.86
Spatially fractionated GRID radiation treatment of advanced neck disease associated with head and neck cancer. Technol Cancer Res Treat (2006) 0.86
Redefining contraindications to laparoscopic colorectal resection for high-risk patients. Surg Endosc (2008) 0.86
External-beam radiotherapy in the management of liver metastases. Semin Oncol (2002) 0.85
Genetic markers predictive of response to induction chemoradiotherapy for locally advanced rectal cancers. J Ky Med Assoc (2007) 0.83
Low-density lipoprotein cholesterol goal attainment among high-risk patients: Does a combined intervention targeting patients and providers work? Am J Manag Care (2006) 0.82
Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells. Mol Cancer Res (2008) 0.82
ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancer. Int J Radiat Oncol Biol Phys (2008) 0.81
Inhibition of transforming growth factor-beta signaling in normal lung epithelial cells confers resistance to ionizing radiation. Int J Radiat Oncol Biol Phys (2007) 0.80
Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates. Cancer Treat Rev (2009) 0.79
Therapeutic advantage of grid irradiation for large single fractions. Int J Radiat Oncol Biol Phys (2004) 0.78
Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma. Cancer (2005) 0.78
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. Clin Cancer Res (2002) 0.77
ACR Appropriateness Criteria: local excision in early-stage rectal cancer. Curr Probl Cancer (2010) 0.77
Increased expression of PSA mRNA during brachytherapy in peripheral blood of patients with prostate cancer. Urology (2002) 0.77
Transanal Minimally Invasive Surgery for Local Excision of Benign and Malignant Rectal Neoplasia: Outcomes From 200 Consecutive Cases With Midterm Follow Up. Ann Surg (2017) 0.77
Uptake of Transanal Total Mesorectal Excision in North America: Initial Assessment of a Structured Training Program and the Experience of Delegate Surgeons. Dis Colon Rectum (2017) 0.76
ACR Appropriateness Criteria: rectal cancer-metastatic disease at presentation. Curr Probl Cancer (2010) 0.76
Will there be a future role for radiation in the neo-adjuvant therapy for rectal cancer? Int J Radiat Oncol Biol Phys (2011) 0.76
ACR Appropriateness Criteria on treatment of anal cancer. J Am Coll Radiol (2007) 0.75
Durable local responses with subtherapeutic doses of concurrent radiation and gemcitabine in a patient with refractory Hodgkin's disease. Clin Adv Hematol Oncol (2003) 0.75
Laparoscopic colorectal surgery in the irradiated pelvis. Am J Surg (2004) 0.75
A phase II study of concomitant hyperfractionated radiation therapy and double dose intra-arterial cisplatin for squamous cell carcinoma of the head and neck. Technol Cancer Res Treat (2002) 0.75